Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Dr Hamish Miller

Back to Search
Colosimo S, Miller H, Koutoukidis DA, Marjot T, Tan GD, Harman DJ, Aithal GP, Manousou P et al. ( 2024 ) . Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD . Diabetes Research and Clinical Practice vol. 217 ,
Miller H, Garrido P, Li W, Kumar R, Gines I, Nikolaou N, Potter T, Bailey M et al. ( 2024 ) . THU-236-YI Oxysterol treatment causes indirect stellate cell activation: a potential mechanism linking steroid metabolising enzyme dysregulation with fibrosis . Journal of Hepatology vol. 80 ,
Miller H, Harman D, Aithal GP, Manousou P, Cobbold JF, Parker R, Sheridan D, Newsome PN et al. ( 2024 ) . Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study . BMJ Open vol. 14 , ( 1 )
Colosimo S, Miller H, Koutoukidis D, Marjot T, Tan G, Harman D, Aithal G, Manousou P et al. ( 2023 ) . The role of glycated haemoglobin in predicting disease severity in non-alcoholic fatty liver disease . Endocrine Abstracts
Li W, Sheridan D, McPherson S, Alazawi W, Abeysekera K, Marjot T, Brennan P, Mahgoub S et al. ( 2023 ) . National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022 . JHEP Reports vol. 5 , ( 12 )
Mir IG, Kumar R, Garrido P, Li W, Miller H, Saihi H, Hood G, Alazawi W ( 2023 ) . FRI-520 B-cell activating factor in non-alcoholic steatohepatitis . Journal of Hepatology vol. 78 ,
Miller H, Colosimo S, Li W, Cobbold J, Alazawi W, Harman D, Aithal G, Manousou P et al. ( 2023 ) . SAT-483 Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review . Journal of Hepatology vol. 78 ,
Back to Search